JPM-OEt 产品活性：JPM-OEt 是一种广谱的半胱氨酸组织蛋白酶 (cysteine cathepsin) 抑制剂。JPM-OEt 在活性位点共价结合，并且不可逆地抑制半胱氨酸组织蛋白酶家族。具有抗肿瘤活性。 产品来源： https://www.medchemexpress.cn/jpm-oet.html 研究领域：Metabolic Enzyme/Protease 作用靶点：作用靶点：Cathepsin In Vivo: JPM-OEt (50 mg/kg; i.p.; daily for 30 days) reduces tumor cathepsin B activity significantly. JPM-OEt (50 mg/kg; i.p.; twice daily for 4 weeks) leads to tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis. JPM-OEt (50 mg/kg; i.p.; daily from 63 to 98 days) causes a significant delay in the increase of tumour burden during the first 2 weeks of treatment. 相关产品：Bioactive Compound Library Plus | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Leupeptin hemisulfate | Aloxistatin | PMSF | E-64 | N-Ethylmaleimide | CA-074 methyl ester | CA-074 | Papain | Calpeptin | LY 3000328 | SID 26681509 | S130 | E 64c | LV-320 | Z-WEHD-FMK | LHVS | NSC 185058 | Z-LVG-CHN2 | Cysteine Protease inhibitor hydrochloride | ONO-5334 | 3-Epiursolic Acid | 2-Cyanopyrimidine | Asperphenamate | ALLM | Aurantiamide acetate | Cathepsin D and E FRET Substrate | K777 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。